Management of radio-contrast allergy in radio-contrast allergic patients undergoing coronary angiography and intervention.

Objectives Radiocontrast agents (RCA) allergy occurs in 0.04 % - 0.22 % of patients.

Gemcitabine-induced coronary vasospasm: A case report.

Gemcitabine is a chemotherapy drug. It is a nucleoside analogue that is usually well tolerated by patients, with myelosuppression (especially thrombocytopenia) as dose-limiting side effect. Other mild to moderate side effects include alopecia, vomiting, nausea, rash, and fever.

Recanalization of total aortoiliac occlusion via contralateral aortofemoral bypass graft.

Severe aortoiliac disease is traditionally treated with aortofemoral bypass (AFB). However, certain recurrent problems typically follow this type of treatment, problems which often require surgical intervention. Presently described is the endovascular recanalization of the native aortoiliac arteries in 2 patients who had undergone AFB.

Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial.

Background: Contrast-induced nephropathy (CIN) remains a common complication of radiographic procedures. Radiocontrast agents can cause a reduction in renal function that may be due to reactive oxygen species. Conflicting evidence suggests that administration of antioxidants prevents CIN.

Short-term effects of fluvastatin therapy on plasma interleukin-10 levels in patients with chronic heart failure.

Background: Experimental data demonstrated that inflammatory mediators, such as pro-inflammatory and anti-inflammatory cytokines and their receptors might have important role in the development and the progression of heart failure (HF). Statins were shown to downregulate inflammatory cytokines in HF. Interleukin (IL)-10 is one of the most important anti-inflammatory cytokines.